Filtros de búsqueda

Lista de obras de Emilio Bria

2-weekly docetaxel: issues for clinical practice.

artículo científico publicado en 2015

A clinical-biological risk stratification model for resected gastric cancer: prognostic impact of Her2, Fhit, and APC expression status.

artículo científico publicado en 2012

A multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer Study

artículo científico publicado en 2018

A novel clinical prognostic score incorporating the number of resected lymph-nodes to predict recurrence and survival in non-small-cell lung cancer

artículo científico publicado en 2009

A phase II study of irinotecan plus chronomodulated oxaliplatin, 5-fluorouracil and folinic acid in advanced colorectal cancer patients

artículo científico publicado en 2003

ALK gene copy number gains in non-small-cell lung cancer: prognostic impact and clinico-pathological correlations

artículo científico publicado en 2016

ALK gene copy number in lung cancer: Unspecific polyploidy versus specific amplification visible as double minutes.

artículo científico publicado en 2016

ALK/EML4 fusion gene may be found in pure squamous carcinoma of the lung.

artículo científico publicado en 2014

AXL Receptor in Breast Cancer: Molecular Involvement and Therapeutic Limitations

artículo científico publicado en 2020

Acute emesis: moderately emetogenic chemotherapy

artículo científico publicado en 2010

Addressing the expected survival benefit for clinical trial design in metastatic castration-resistant prostate cancer: Sensitivity analysis of randomized trials

artículo científico publicado en 2015

Adenocarcinoma of the paraurethral glands: a case report

scientific article published on 07 March 2014

Adjuvant Chemotherapy for Bladder Cancer: The Chance for Meta-analyses Comparison

artículo científico publicado en 2007

Adjuvant chemotherapy for non-small cell lung cancer

scientific article published on 01 May 2007

Adjuvant chemotherapy in muscle-invasive bladder carcinoma

artículo científico publicado en 2006

Adjuvant treatment for resected renal cell carcinoma: are all strategies equally negative? Potential implications for trial design with targeted agents.

artículo científico publicado en 2013

Advances towards the design and development of personalized non-small-cell lung cancer drug therapy.

artículo científico publicado en 2013

An overview of angiogenesis inhibitors in Phase II studies for non-small-cell lung cancer

artículo científico

Anti-angiogenic drugs and biomarkers in non-small-cell lung cancer: a 'hard days night'.

artículo científico publicado en 2014

Antiblastic chemotherapy in the presence of abdominal aorta aneurysm (AAA): guidelines.

artículo científico publicado en 1999

Aromatase inhibitors in post-menopausal metastatic breast carcinoma

artículo científico publicado en 2007

Avoiding chemotherapy for advanced nononcogene addicted NSCLC overexpressing PD-L1: Rule or option?

scientific article published on 01 June 2018

BE-POSITIVE: Beyond progression after tyrosine kinase inhibitor in EGFR- positive non small cell lung cancer patients: Results from a multicenter Italian observational study.

artículo científico publicado en 2016

BIM and mTOR expression levels predict outcome to erlotinib in EGFR-mutant non-small-cell lung cancer

artículo científico publicado en 2015

BMI variation increases recurrence risk in women with early-stage breast cancer

artículo científico publicado en 2014

Balancing activity and tolerability of neoadjuvant paclitaxel- and docetaxel-based chemotherapy for HER2-positive early stage breast cancer: sensitivity analysis of randomized trials

artículo científico publicado en 2015

Benefit of taxanes as adjuvant chemotherapy for early breast cancer

artículo científico publicado en 2006

Biosimilars as a strategy to improve sustainability.

artículo científico publicado en 2017

Brain metastases from solid tumors: disease outcome according to type of treatment and therapeutic resources of the treating center

artículo científico publicado en 2011

CXC and CC chemokines as angiogenic modulators in nonhaematological tumors.

artículo científico publicado en 2014

Capecitabine and celecoxib as second-line treatment of advanced pancreatic and biliary tract cancers

artículo científico publicado en 2009

Cardiotoxicity and incidence of brain metastases after adjuvant trastuzumab for early breast cancer: the dark side of the moon? A meta-analysis of the randomized trials

artículo científico publicado en 2007

Catheter-associated thrombosis: thromboprophylaxis for cancer patients who carry factor V Leiden?

artículo científico publicado en 2005

Cellular and molecular biology of small cell lung cancer: an overview

artículo científico publicado en 2016

Chemotherapy-induced amenorrhea in early breast cancer

artículo científico publicado en 2005

Chemotherapy-induced nausea and vomiting (CINV) in patients with advanced lung cancer during the first-line treatment: assessment by physicians, nurses, and patients from an Italian multicenter survey.

artículo científico publicado en 2017

Clinical Evaluation of the Use of Exemestane as Further Hormonal Therapy after Nonsteroidal Aromatase Inhibitors in Postmenopausal Metastatic Breast Cancer Patients

artículo científico publicado en 2007

Clinical impact of anti-epidermal growth factor receptor monoclonal antibodies in first-line treatment of metastatic colorectal cancer

artículo científico publicado en 2011

Clinical implication of changes in body composition and weight in patients with early-stage and metastatic breast cancer

article

Clinical results of randomized trials and 'real-world' data exploring the impact of Bevacizumab for breast cancer: opportunities for clinical practice and perspectives for research.

artículo científico publicado en 2017

Clinico-pathological nomogram for predicting BRAF mutational status of metastatic colorectal cancer.

artículo científico publicado en 2015

Comparison Between Prognostic Classifications in De Novo Metastatic Hormone Sensitive Prostate Cancer

artículo científico publicado en 2018

Comprehensive molecular portrait using next generation sequencing of resected intestinal-type gastric cancer patients dichotomized according to prognosis

artículo científico publicado en 2016

Consensus recommendations for the prevention of vomiting and nausea following high-emetic-risk chemotherapy.

artículo científico publicado en 2010

Correction: The Promher Study: An Observational Italian Study on Adjuvant Therapy for HER2-Positive, pT1a-b pN0 Breast Cancer

artículo científico publicado en 2015

Crizotinib in MET-Deregulated or ROS1-Rearranged Pretreated Non-Small Cell Lung Cancer (METROS): A Phase II, Prospective, Multicenter, Two-Arms Trial

artículo científico publicado en 2019

Current and developing therapies for the treatment of non-small cell lung cancer with ALK abnormalities: update and perspectives for clinical practice.

artículo científico publicado en 2016

Deciphering Crosstalk Circuits in Non-small Cell Lung Cancers with an Increasing Interval Length of Low Dose CT Screening

artículo científico publicado en 2015

Differential Activity of Nivolumab, Pembrolizumab and MPDL3280A according to the Tumor Expression of Programmed Death-Ligand-1 (PD-L1): Sensitivity Analysis of Trials in Melanoma, Lung and Genitourinary Cancers

artículo científico publicado en 2015

Discordance in pathology report after central pathology review: Implications for breast cancer adjuvant treatment

artículo científico publicado en 2016

Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting

artículo científico publicado en 2019

Do adjuvant aromatase inhibitors increase the cardiovascular risk in postmenopausal women with early breast cancer? Meta-analysis of randomized trials

artículo científico publicado en 2008

Do immune checkpoint inhibitors need new studies methodology?

artículo científico publicado en 2018

Does hormone treatment added to radiotherapy improve outcome in locally advanced prostate cancer?: meta-analysis of randomized trials

artículo científico publicado en 2009

Does low-molecular-weight heparin influence cancer-related mortality?

artículo científico publicado en 2006

EGFR molecular profiling in advanced NSCLC: a prospective phase II study in molecularly/clinically selected patients pretreated with chemotherapy.

artículo científico publicado en 2012

Early recurrence risk: aromatase inhibitors versus tamoxifen.

artículo científico publicado en 2010

Early switch with aromatase inhibitors as adjuvant hormonal therapy for postmenopausal breast cancer: Pooled-analysis of 8794 patients

artículo científico publicado en 2006

Effect of Contract Research Organization Bureaucracy in Clinical Trial Management: A Model From Lung Cancer.

artículo científico publicado en 2017

Efficacy of neurokinin-1 receptor antagonists in the prevention of chemotherapy-induced nausea and vomiting in patients receiving carboplatin-based chemotherapy: A systematic review and meta-analysis.

artículo científico publicado en 2018

Extra-nodal extension of sentinel lymph node metastasis is a marker of poor prognosis in breast cancer patients: A systematic review and an exploratory meta-analysis.

artículo científico publicado en 2016

FGFR-1 amplification in metastatic lymph-nodal and haematogenous lobular breast carcinoma.

artículo científico publicado en 2012

Factorial design for randomized clinical trials

artículo científico publicado en 2006

Final data of an Italian multicentric survey about counseling for smoking cessation in patients with diagnosis of a respiratory disease

First-line erlotinib and fixed dose-rate gemcitabine for advanced pancreatic cancer

artículo científico publicado en 2013

Fixed dose-rate gemcitabine infusion as first-line treatment for advanced-stage carcinoma of the pancreas and biliary tree

artículo científico publicado en 2005

Gastrointestinal Cancer Patient Nutritional Management: From Specific Needs to Novel Epigenetic Dietary Approaches

artículo científico publicado en 2022

Gemcitabine-based combinations for inoperable pancreatic cancer: Have we made real progress?

artículo científico publicado en 2007

Genetic alterations analysis in prognostic stratified groups identified TP53 and ARID1A as poor clinical performance markers in intrahepatic cholangiocarcinoma.

artículo científico publicado en 2018

Going towards a precise definition of the therapeutic management of de-novo metastatic castration sensitive prostate cancer patients: How prognostic classification impact treatment decisions

artículo científico publicado en 2019

Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference

artículo científico publicado en 2010

Guidelines for the control of nausea and vomiting with chemotherapy of low or minimal emetic potential

scientific article published on 29 August 2010

HER2/neu gene determination in women screened for breast carcinoma: how screening programs reduce the skyrocketing cost of targeted therapy

article

High-throughput mutation profiling identifies novel molecular dysregulation in high-grade intraepithelial neoplasia and early gastric cancers.

artículo científico publicado en 2013

Human epidermal growth factor receptor 2-positive breast cancer: heat shock protein 90 overexpression, Ki67 proliferative index, and topoisomerase II-α co-amplification as predictors of pathologic complete response to neoadjuvant chemotherapy with t

artículo científico publicado en 2014

Hyperprogressive Disease in Patients With Advanced Non-Small Cell Lung Cancer Treated With PD-1/PD-L1 Inhibitors or With Single-Agent Chemotherapy

scientific article published on 01 November 2018

Immune checkpoint inhibitors for non-small-cell lung cancer: does that represent a 'new frontier'?

artículo científico publicado en 2015

Immunotherapy versus standard of care in metastatic renal cell carcinoma. A systematic review and meta-analysis

artículo científico publicado en 2018

Impact of BMI on HER2+ metastatic breast cancer patients treated with pertuzumab and/or trastuzumab emtansine. Real-world evidence

artículo científico publicado en 2020

Impact of hormonal treatment duration in combination with radiotherapy for locally advanced prostate cancer: meta-analysis of randomized trials

artículo científico publicado en 2010

Impact of neoadjuvant single or dual HER2 inhibition and chemotherapy backbone upon pathological complete response in operable and locally advanced breast cancer: Sensitivity analysis of randomized trials.

artículo científico publicado en 2014

Integrating the molecular background of targeted therapy and immunotherapy in lung cancer: a way to explore the impact of mutational landscape on tumor immunogenicity

artículo científico publicado en 2015

Interfering with CCL5/CCR5 at the Tumor-Stroma Interface

artículo científico publicado en 2016

Is recurrent venous thromboembolism after therapy reduced by low-molecular-weight heparin compared with oral anticoagulants?

artículo científico publicado en 2006

Italian Survey on adjuvant treatment of non-small cell lung cancer (ISA)

article

Low-molecular-weight heparin versus oral anticoagulant therapy for the long-term treatment of symptomatic venous thromboembolism: Is there any difference in cancer-related mortality?

artículo científico publicado en 2005

Lumpectomy and tamoxifen alone without additional radiotherapy for women 70 years of age or older with estrogen receptor-positive breast cancer.

artículo científico publicado en 2005

Lung adenocarcinoma patient refractory to gefitinib and responsive to crizotinib, with concurrent rare mutation of the epidermal growth factor receptor (L861Q) and increased ALK/MET/ROS1 gene copy number.

artículo científico publicado en 2013

Lung and Gut Microbiota as Potential Hidden Driver of Immunotherapy Efficacy in Lung Cancer

artículo científico publicado en 2019

Lung neuroendocrine tumours: deep sequencing of the four World Health Organization histotypes reveals chromatin-remodelling genes as major players and a prognostic role for TERT, RB1, MEN1 and KMT2D.

artículo científico publicado en 2016

MET exon 14 juxtamembrane splicing mutations: clinical and therapeutical perspectives for cancer therapy

artículo científico publicado en 2017

Magnitude of benefit of adjuvant chemotherapy for non-small cell lung cancer: meta-analysis of randomized clinical trials

artículo científico publicado en 2008

Magnitude of benefit of the addition of bevacizumab to first-line chemotherapy for metastatic colorectal cancer: meta-analysis of randomized clinical trials

artículo científico publicado en 2010

Magnitude of risks and benefits of the addition of bevacizumab to chemotherapy for advanced breast cancer patients: Meta-regression analysis of randomized trials

artículo científico publicado en 2011

Maintenance therapy in NSCLC: why? To whom? Which agent? ⬇️

artículo científico publicado en 2011

Maintenance therapy in epithelial ovarian cancer: from chemotherapy to targeted agents

artículo científico publicado en 2014

Major bleedings in the comparisons between low-molecular weight heparin versus oral anticoagulant therapy for venous thromboembolism

artículo científico publicado en 2006

Malignant bronchial Abrikossoff's tumor and small cell lung cancer: a case report and review.

artículo científico publicado en 2001

Management of locally advanced non-small cell lung cancer in the modern era: A national Italian survey on diagnosis, treatment and multidisciplinary approach

artículo científico publicado en 2019

Melanoma: oncogenic drivers and the immune system

artículo científico publicado en 2015

Metastatic pancreatic cancer: Is there a light at the end of the tunnel?

artículo científico publicado en 2015

Metformin Enhances Cisplatin-Induced Apoptosis and Prevents Resistance to Cisplatin in Co-mutated KRAS/LKB1 NSCLC

scientific article published on 24 August 2018

Molecular and genetic bases of pancreatic cancer.

artículo científico

Molecular heterogeneity assessment by next-generation sequencing and response to gefitinib of EGFR mutant advanced lung adenocarcinoma.

artículo científico publicado en 2015

Molecular profiling in Italian patients with advanced non-small-cell lung cancer: An observational prospective study.

artículo científico publicado en 2017

Molecular typing of lung adenocarcinoma on cytological samples using a multigene next generation sequencing panel

artículo científico publicado en 2013

Most high-grade neuroendocrine tumours of the lung are likely to secondarily develop from pre-existing carcinoids: innovative findings skipping the current pathogenesis paradigm

artículo científico publicado en 2018

Moving towards a customized approach for drug development: lessons from clinical trials with immune checkpoint inhibitors in lung cancer

artículo científico publicado en 2015

Necitumumab in the treatment of non-small-cell lung cancer: clinical controversies

artículo científico publicado en 2018

Neoadjuvant strategies for triple negative breast cancer: 'state-of-the-art' and future perspectives.

artículo científico publicado en 2014

New aromatase inhibitors as second-line endocrine therapy in postmenopausal patients with metastatic breast carcinoma: a pooled analysis of the randomized trials

artículo científico publicado en 2005

Next-generation repeat-free FISH probes for DNA amplification in glioblastoma in vivo: Improving patient selection to MDM2-targeted inhibitors

artículo científico publicado en 2016

Non-small cell lung cancer: early stages

artículo científico publicado en 2006

Oncogene addiction in non-small cell lung cancer: Focus on ROS1 inhibition

artículo científico publicado en 2017

Oncogene-Addicted Non-Small-Cell Lung Cancer: Treatment Opportunities and Future Perspectives

artículo científico publicado en 2020

Oral ondansetron is highly active as rescue antiemetic treatment for moderately emetogenic chemotherapy: results of a randomized phase II study

artículo científico publicado en 2008

Outcome of advanced NSCLC patients harboring sensitizing EGFR mutations randomized to EGFR tyrosine kinase inhibitors or chemotherapy as first-line treatment: a meta-analysis

artículo científico publicado en 2011

Outcomes of First-Generation EGFR-TKIs Against Non-Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Post Hoc Analysis of the BE-POSITIVE Study

artículo científico publicado en 2017

PIK3CA mutations are associated with reduced pathological complete response rates in primary HER2-positive breast cancer: pooled analysis of 967 patients from five prospective trials investigating lapatinib and trastuzumab

artículo científico publicado en 2018

PIK3CA mutations are associated with reduced pathological complete response rates in primary HER2-positive breast cancer: pooled analysis of 967 patients from five prospective trials investigating lapatinib and trastuzumab.

artículo científico publicado en 2016

PROFILing non-small-cell lung cancer patients for treatment with crizotinib according to anaplastic lymphoma kinase abnormalities: translating science into medicine.

artículo científico

PTEN in Lung Cancer: Dealing with the Problem, Building on New Knowledge and Turning the Game Around

scientific article published on 09 August 2019

Palbociclib Plus Fulvestrant or Everolimus Plus Exemestane for Pretreated Advanced Breast Cancer with Lobular Histotype in ER+/HER2- Patients: A Propensity Score-Matched Analysis of a Multicenter Retrospective Patient Series

scientific article published on 18 December 2020

Palonosetron for the prevention of chemotherapy-induced nausea and vomiting in glioblastoma patients treated with temozolomide: a phase II study

artículo científico publicado en 2010

Peripheral neurotoxicity of weekly paclitaxel chemotherapy: a schedule or a dose issue?

artículo científico publicado en 2007

Platelet-derived growth factor receptor inhibitors for non-small cell lung cancer: is the odyssey over?

artículo científico publicado en 2016

Platelets and their role in cancer evolution and immune system

artículo científico publicado en 2015

Predictive and Prognostic Role of Tumor-Infiltrating Lymphocytes for Early Breast Cancer According to Disease Subtypes: Sensitivity Analysis of Randomized Trials in Adjuvant and Neoadjuvant Setting

artículo científico publicado en 2016

Predictive role of erythrocyte macrocytosis during treatment with pemetrexed in advanced non-small cell lung cancer patients

artículo científico publicado en 2015

Predictors of outcome for patients with lung adenocarcinoma carrying the epidermal growth factor receptor mutation receiving 1st-line tyrosine kinase inhibitors: Sensitivity and meta-regression analysis of randomized trials.

artículo científico

Primary chemotherapy with epirubicin and vinorelbine in women with locally advanced breast cancer.

artículo científico publicado en 2005

Prognostic Model for Resected Squamous-Cell Lung Cancer: External Multicenter Validation and Propensity Score Analysis exploring the Impact of Adjuvant and Neoadjuvant Treatment.

artículo científico publicado en 2017

Prognostic Value of Beta-Tubulin-3 and c-Myc in Muscle Invasive Urothelial Carcinoma of the Bladder.

artículo científico publicado en 2015

Prognostic and predictive factors in patients treated with chemotherapy for advanced urothelial cancer: where do we stand?

artículo científico publicado en 2015

Prognostic impact of alternative splicing-derived hMENA isoforms in resected, node-negative, non-small-cell lung cancer.

artículo científico publicado en 2014

Prognostic impact of early nutritional support in patients affected by locally advanced and metastatic pancreatic ductal adenocarcinoma undergoing chemotherapy.

artículo científico publicado en 2018

Prognostic impact of proliferation for resected early stage 'pure' invasive lobular breast cancer: Cut-off analysis of Ki67 according to histology and clinical validation

artículo científico publicado en 2017

Prognostic model for advanced breast carcinoma with luminal subtype and impact of hormonal maintenance: Implications for post-progression and conditional survival

artículo científico publicado en 2016

Prognostic stratification of node-negative NSCLC patients: is it worthwhile?

artículo científico publicado en 2014

Progression-free survival as primary end point in advanced non-small-cell lung cancer: does the size matter?

artículo científico publicado en 2008

Progression-free survival as primary endpoint in randomized clinical trials of targeted agents for advanced renal cell carcinoma. Correlation with overall survival, benchmarking and power analysis.

artículo científico publicado en 2014

Pulmonary Adenocarcinoma With Enteric Differentiation

artículo científico publicado en 2018

Pulmonary adenocarcinoma with enteric differentiation: Dissecting oncogenic genes alterations with DNA sequencing and FISH analysis.

artículo científico publicado en 2017

Putative predictors of efficacy for immune checkpoint inhibitors in non-small-cell lung cancer: facing the complexity of the immune system

artículo científico publicado en 2017

Quantitative score modulation of HSP90 and HSP27 in clear cell renal cell carcinoma

artículo científico publicado en 2014

Randomised phase II study of standard versus chronomodulated CPT-11 plus chronomodulated 5-fluorouracil and folinic acid in advanced colorectal cancer patients

artículo científico publicado en 2006

Re: Survival with aromatase inhibitors and inactivators versus standard hormonal therapy in advanced breast cancer: meta-analysis

artículo científico publicado en 2007

Reprofiling Metastatic Samples for Chromosome 9p and 14q Aberrations as a Strategy to Overcome Tumor Heterogeneity in Clear-cell Renal Cell Carcinoma

artículo científico publicado en 2015

Revising PTEN in the Era of Immunotherapy: New Perspectives for an Old Story

scientific article published on 10 October 2019

Risk Stratification Model for Resected Squamous-Cell Lung Cancer Patients According to Clinical and Pathological Factors

artículo científico publicado en 2015

Role of mTOR Signaling in Tumor Microenvironment: An Overview

artículo científico publicado en 2018

Second- and third-generation aromatase inhibitors as first-line endocrine therapy in postmenopausal metastatic breast cancer patients: a pooled analysis of the randomised trials.

artículo científico publicado en 2006

Second-line therapy for metastatic urothelial carcinoma: Defining the best treatment option among immunotherapy, chemotherapy, and antiangiogenic targeted therapies. A systematic review and meta-analysis

artículo científico publicado en 2019

Sequencing new agents after docetaxel in patients with metastatic castration-resistant prostate cancer

artículo científico

Sequential therapy in metastatic clear cell renal carcinoma: TKI-TKI vs TKI-mTOR.

artículo científico

Serial 18F-choline-PET imaging in patients receiving enzalutamide for metastatic castration-resistant prostate cancer: response assessment and imaging biomarkers.

artículo científico publicado en 2016

Should Subgroup Analysis of Randomized Clinical Trials Have a Direct Impact on Clinical Practice?

artículo científico publicado en 2007

Skeletal Muscle Loss during Multikinase Inhibitors Therapy: Molecular Pathways, Clinical Implications, and Nutritional Challenges

scientific article published on 12 October 2020

Skin testing and hypersensitivity reactions to oxaliplatin

artículo científico publicado en 2003

Smoking habit and hospitalization for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-related pneumonia: The unsolved paradox behind the evidence

artículo científico publicado en 2020

Sorafenib for lung cancer: is the "Battle" still open?

artículo científico publicado en 2012

Subpopulation Treatment Effect Pattern Plot (STEPP) analysis of Ki67 assay according to histology: prognostic relevance for resected early stage 'pure' and 'mixed' lobular breast cancer

artículo científico publicado en 2016

Tackling ALK in non-small cell lung cancer: the role of novel inhibitors

artículo científico publicado en 2016

Targeting targeted agents: open issues for clinical trial design

artículo científico publicado en 2009

Targeting the epidermal growth factor receptor in solid tumors: focus on safety.

artículo científico publicado en 2014

Taxanes as primary chemotherapy for early breast cancer: meta-analysis of randomized trials

artículo científico publicado en 2008

Taxanes with anthracyclines as first-line chemotherapy for metastatic breast carcinoma

artículo científico publicado en 2005

Ten years of experience with weekly chemotherapy in metastatic breast cancer patients: multivariate analysis of prognostic factors

artículo científico publicado en 2006

The Cardiovascular Toxicity of Abiraterone and Enzalutamide in Prostate Cancer.

artículo científico publicado en 2017

The Disabled homolog 2 controls pro-metastatic activity of tumor-associated macrophages

artículo científico publicado en 2020

The Facts about Food after Cancer Diagnosis: A Systematic Review of Prospective Cohort Studies

scientific article published on 05 August 2020

The Promher Study: An Observational Italian Study on Adjuvant Therapy for HER2-Positive, pT1a-b pN0 Breast Cancer

artículo científico publicado en 2015

The coming of ramucirumab in the landscape of anti-angiogenic drugs: potential clinical and translational perspectives.

artículo científico

The development of PARP as a successful target for cancer therapy

artículo científico publicado en 2017

The identification of a small but significant subset of patients still targetable with anti-HER2 inhibitors when affected by triple negative breast carcinoma

artículo científico publicado en 2013

The incidence and relative risk of pulmonary toxicity in patients treated with anti-PD1/PD-L1 therapy for solid tumors: a meta-analysis of current studies

artículo científico publicado en 2017

The obesity paradox in cancer: clinical insights and perspectives

scientific article published on 28 February 2018

Tracking MET de-addiction in lung cancer: A road towards the oncogenic target.

artículo científico publicado en 2017

Tracking occult pN2 disease after mediastinal dissection in early stage lung cancer

artículo científico publicado en 2017

Trastuzumab cardiotoxicity: biological hypotheses and clinical open issues

artículo científico publicado en 2008

Trastuzumab plus weekly epirubicin and paclitaxel for locally advanced and metastatic breast cancer: preliminary results of a feasibility-phase II study aimed at cardiotoxicity

artículo científico publicado en 2009

Treatment of Locally Advanced Gastric Cancer (LAGC): Back to Lauren's Classification in Pan-Cancer Analysis Era?

scientific article published on 01 July 2020

Treatment of Unfit Patients With Advanced Non-Small-Cell Lung Cancer: Definition Criteria According an Expert Panel.

artículo científico

Treatment of resected non-small-cell lung cancer

scientific article published on 01 October 2005

Troponin-T and myoglobin plus echocardiographic evaluation for monitoring early cardiotoxicity of weekly epirubicin???paclitaxel in metastatic breast cancer patients

artículo científico publicado en 2007

True 3q chromosomal amplification in squamous cell lung carcinoma by FISH and aCGH molecular analysis: impact on targeted drugs

artículo científico publicado en 2012

Tubulin inhibitors in non-small cell lung cancer: looking back and forward

artículo científico publicado en 2016

Unmasking the impact of Rictor in cancer: novel insights of mTORC2 complex

artículo científico publicado en 2018

Weekly docetaxel as second line chemotherapy for advanced non-small-cell lung cancer: Meta-analysis of randomized trials

artículo científico publicado en 2006

Weekly docetaxel in pretreated metastatic breast cancer patients: a phase I-II study

artículo científico publicado en 2005

Weekly epirubicin and paclitaxel with granulocyte colony-stimulating factor support in previously untreated metastatic breast cancer patients: a phase II study.

artículo científico publicado en 2007

Weekly paclitaxel, 5-fluorouracil and folinic acid with granulocyte colony-stimulating factor support in metastatic breast cancer patients: a phase II study

artículo científico publicado en 2006

Zoledronic acid-associated thrombotic thrombocytopenic purpura.

artículo científico publicado en 2004

[Metastatic breast cancer: is global survival increase a realistic endpoint in phase III clinical trials? Studies on taxanes; studies on trastuzumab]

scientific article published on 01 July 2004

c-MYC Expression Is a Possible Keystone in the Colorectal Cancer Resistance to EGFR Inhibitors

scientific article published on 10 March 2020

eComment. Does resected lymph-node number influence survival in non-small cell lung cancer?

artículo científico publicado en 2015

hMENA splicing program impacts the clinical outcome of early stage lung cancer patients. How and why?

artículo científico publicado en 2014

mTOR Cross-Talk in Cancer and Potential for Combination Therapy.

artículo científico publicado en 2018

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda